Publicaciones en colaboración con investigadores/as de Hospital Ramón y Cajal (25)

2024

  1. Fight Retinal Blindness SPAIN. Report 3: clinical outcomes of vascular endothelial growth factor inhibitors in low vision eyes with neovascular age-related macular degeneration. A national database study

    Eye (Basingstoke)

  2. Macular Neovascularization Type Influence on Anti-VEGF Intravitreal Therapy Outcomes in Age-Related Macular Degeneration

    Ophthalmology Retina, Vol. 8, Núm. 4, pp. 350-359

  3. PRPH2-Related Retinal Dystrophies: Mutational Spectrum in 103 Families from a Spanish Cohort

    International Journal of Molecular Sciences, Vol. 25, Núm. 5

2023

  1. Artificial intelligence-based fluid quantification and associated visual outcomes in a real-world, multicentre neovascular age-related macular degeneration national database

    British Journal of Ophthalmology, Vol. 108, Núm. 2, pp. 253-262

  2. Ocular involvement in adult and paediatric patients with monogenic autoinflammatory diseases: a Spanish multicentre retrospective study

    Clinical and experimental rheumatology, Vol. 41, Núm. 10, pp. 2105-2114

  3. Predictive Factors and Management of Macular Edema after Retropupillary Iris-Claw Intraocular Lens Implantation in Aphakia: National Multicenter Audit—Report 2

    Journal of Clinical Medicine, Vol. 12, Núm. 2

2022

  1. Guía de recomendaciones para el manejo de brolucizumab

    Archivos de la Sociedad Española de Oftalmologia, Vol. 97, Núm. 11, pp. 626-638

  2. Incidence, Risk Factors, and Outcomes of Rhegmatogenous Retinal Detachment after Intravitreal Injections of Anti-VEGF for Retinal Diseases: Data from the Fight Retinal Blindness! Registry

    Ophthalmology Retina, Vol. 6, Núm. 11, pp. 1044-1053

  3. Vogt-Koyanagi-Harada disease in Spain

    European Journal of Ophthalmology, Vol. 32, Núm. 3, pp. 1547-1554

2021

  1. RETROPUPILLARY IRIS-CLAW INTRAOCULAR LENS AND PARS PLANA VITRECTOMY IN APHAKIA MANAGEMENT: A National Multicenter Audit

    Retina, Vol. 41, Núm. 10, pp. 2048-2058

  2. Recommendations for ophthalmologic practice during the easing of COVID-19 control measures

    Acta Ophthalmologica, Vol. 99, Núm. 7, pp. e973-e983

2020

  1. Bimonthly, treat-and-extend and as-needed ranibizumab in naïve neovascular age-related macular degeneration patients: 12-month outcomes of a randomized study

    Acta Ophthalmologica, Vol. 98, Núm. 7, pp. e820-e829

  2. Macular ganglion cell complex thinning in children with visual field defects due to central nervous system pathology

    Eye (Basingstoke), Vol. 34, Núm. 9, pp. 1570-1576

  3. Optimization of Diabetic Macular Edema Management in the Real World: A Model of Excellence in Retina Units: The EMUREX Initiative

    Ophthalmologica, Vol. 243, Núm. 5, pp. 379-390

  4. Recomendaciones para la atención oftalmológica durante el estado de alarma por la pandemia de enfermedad por coronavirus COVID-19

    Archivos de la Sociedad Española de Oftalmologia, Vol. 95, Núm. 6, pp. 300-310

2019

  1. Comparative Study of Infliximab Versus Adalimumab in Refractory Uveitis due to Behçet's Disease: National Multicenter Study of 177 Cases

    Arthritis and Rheumatology, Vol. 71, Núm. 12, pp. 2081-2089

2018

  1. Parental mosaicism in PAX6 causes intra-familial variability: Implications for genetic counseling of congenital aniridia and microphthalmia

    Frontiers in Genetics, Vol. 9, Núm. OCT

2017

  1. Prevalence of Vitreoretinal Interface Abnormalities on Spectral-Domain OCT in Healthy Participants over 45 Years of Age

    Ophthalmology Retina

2013

  1. Co-isolation of Vahlkampfia and acanthamoeba in acanthamoeba-like keratitis in a Spanish population

    Cornea, Vol. 32, Núm. 5, pp. 608-614

  2. Usefulness of adalimumab in the treatment of refractory uveitis associated with juvenile idiopathic arthritis

    Mediators of Inflammation, Vol. 2013